Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Gabutti

Showing results (101-110 of 126) with videos related to

Pageof 13
Sort By:
Human Vaccines|September 20, 2008
Monitoring the rate of hospitalization before rotavirus immunization in Italy utilizing ICD9-CM regional databasesFederico Marchetti, Barouk Assael, Giovanni Gabutti, et al.
Respiration; International Review of Thoracic Diseases|March 9, 2025
Vaccination Strategies in Respiratory Diseases: Recommendation from AIPO-ITS/ETS, SIMIT, SIP/IRS, and SItIClaudio Micheletto, Stefano Aliberti, Massimo Andreoni, et al.
Vaccine|December 12, 2017
One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of lifeOuzama Henry, Jerzy Brzostek, Hanna Czajka, et al.
Vaccine|May 31, 2024
Seroprevalence of measles antibodies in the Italian general population in 2019-2020Tiziana Grassi, Francesco Bagordo, Maria Cristina Rota, et al.
Vaccine|September 25, 2018
Corrigendum to "One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life" [Vaccine 36 (2018) 381-387]Ouzama Henry, Jerzy Brzostek, Hanna Czajka, et al.
Igiene E Sanita Pubblica|January 9, 2007
[Hospitalisation associated with Rotavirus gastroenteritis in Italy, 2001-2003, evaluated by means of ICD9-CM diagnostic codes]Alessia Marocco, Baroukh Assael, Giovanni Gabutti, et al.
The Pediatric Infectious Disease Journal|July 10, 2012
Safety of a 2-dose regimen of a combined measles, mumps, rubella and varicella live vaccine manufactured with recombinant human albuminGabriela Rüger, Giovanni Gabutti, Hans Rümke, et al.
Vaccine|May 18, 2024
Seroprotection against tetanus in the Italian general populationFrancesco Bagordo, Tiziana Grassi, Maria Cristina Rota, et al.
Aging Clinical and Experimental Research|January 10, 2022
Improving vaccination rates in older adults and at-risk groups: focus on pertussisJung-Hyun Choi, Jaime Correia de Sousa, Monica Fletcher, et al.
Igiene E Sanita Pubblica|April 29, 2014
[Herpes Zoster and its prevention in Italy. Scientific consensus statement]Elisabetta Franco, Giovanni Gabutti, Paolo Bonanni, et al.
Pageof 13

Showing results (101-110 of 126) with videos related to

Sort By:
Pageof 13
Human Vaccines|September 20, 2008
Monitoring the rate of hospitalization before rotavirus immunization in Italy utilizing ICD9-CM regional databasesFederico Marchetti, Barouk Assael, Giovanni Gabutti, et al.
Respiration; International Review of Thoracic Diseases|March 9, 2025
Vaccination Strategies in Respiratory Diseases: Recommendation from AIPO-ITS/ETS, SIMIT, SIP/IRS, and SItIClaudio Micheletto, Stefano Aliberti, Massimo Andreoni, et al.
Vaccine|December 12, 2017
One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of lifeOuzama Henry, Jerzy Brzostek, Hanna Czajka, et al.
Vaccine|May 31, 2024
Seroprevalence of measles antibodies in the Italian general population in 2019-2020Tiziana Grassi, Francesco Bagordo, Maria Cristina Rota, et al.
Vaccine|September 25, 2018
Corrigendum to "One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life" [Vaccine 36 (2018) 381-387]Ouzama Henry, Jerzy Brzostek, Hanna Czajka, et al.
Igiene E Sanita Pubblica|January 9, 2007
[Hospitalisation associated with Rotavirus gastroenteritis in Italy, 2001-2003, evaluated by means of ICD9-CM diagnostic codes]Alessia Marocco, Baroukh Assael, Giovanni Gabutti, et al.
The Pediatric Infectious Disease Journal|July 10, 2012
Safety of a 2-dose regimen of a combined measles, mumps, rubella and varicella live vaccine manufactured with recombinant human albuminGabriela Rüger, Giovanni Gabutti, Hans Rümke, et al.
Vaccine|May 18, 2024
Seroprotection against tetanus in the Italian general populationFrancesco Bagordo, Tiziana Grassi, Maria Cristina Rota, et al.
Aging Clinical and Experimental Research|January 10, 2022
Improving vaccination rates in older adults and at-risk groups: focus on pertussisJung-Hyun Choi, Jaime Correia de Sousa, Monica Fletcher, et al.
Igiene E Sanita Pubblica|April 29, 2014
[Herpes Zoster and its prevention in Italy. Scientific consensus statement]Elisabetta Franco, Giovanni Gabutti, Paolo Bonanni, et al.
Pageof 13